Metro Healthcare Indonesia Tbk. vs Tripar Multivision Plus Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp428 (market cap 14.23T, 346.3K 24h volume), while Tripar Multivision Plus Tbk. trades at Rp199 (market cap 1.39T, 201.9K 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 10.2× Tripar Multivision Plus Tbk.'s market cap, and Metro Healthcare Indonesia Tbk. is more actively traded (346.3K versus 201.9K). Which is the better fit depends on your goals.
| CARE | RAAM | |
|---|---|---|
Market Cap | 14.23T | 1.39T |
Volume | 346.3K | 201.9K |
Lot | 3.46K | 2.02K |
Turnover | 147.93M | 40.78M |
Average Price | 427.18 | 201.96 |
Value | 147.93M | 40.78M |
Indicative Equilibrium Price | 428 | 199 |
Indicative Equilibrium Volume | 10 | 6 |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Tripar Multivision Plus Tbk (“the Company”) was establishedbased on Deed of Establishment of Limited Liability Company No. 17 dated 6 December 1990 drawn up before Adlan Yulizar, S.H., notary in Jakarta.
Read more on RAAM →